CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting ...Middle East

– Data presentation on spleen volume reduction in patients with myelofibrosis also accepted for poster discussion – SEATTLE, May 1, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel...

Hence then, the article about cti biopharma announces two abstracts accepted for presentation at the 2023 american society of clinical oncology asco annual meeting was published today ( Monday 01/05/2023 - 02:05 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CTI BioPharma Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting )

Also on site :

• Kentucky congressman announces death of longtime staffer, campaign manager
• Camarillo man arrested after stolen camera reactivated and installed on the exterior of a home
• Environmental groups file emergency lawsuit to halt Sable Offshore’s restart of oil production